send to a friend by email

Jerusalem Pharmaceutical earns a pretax profit of JD2.63 million in 2010

2011-02-20

Jerusalem Pharmaceutical disclosed the preliminary annual financial statements for the year 2010, which indicated pretax profit of JD 2.63 million compared to JD 1.65  million in 2009.

 To view Sahem’s report regarding the company’s financial results, click on the following link:

Sahem Fact Sheet 2010